ClinicalTrials.Veeva

Menu

Effect of Intrathecal vs Intraarticular Dexmedetomidine on Postoperative Pain Following Arthroscopy

A

Assiut University

Status

Completed

Conditions

Postoperative Pain

Treatments

Drug: Intraarticular Dexmedetomidine
Drug: Intrathecal Dexmedetomidine
Drug: Bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT02581566
01003060215

Details and patient eligibility

About

Comparison between intrathecal Dexmedetomidine versus Intraarticular Dexmedetomidine on postoperative pain after knee arthroscopy.

Enrollment

90 patients

Sex

All

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients, ASA I-II, undergoing knee arthroscopy under spinal anesthesia.

Exclusion criteria

  • Absolute or relative contraindications to spinal anesthesia, allergy to dexmedetomidine or chronic pain treatment.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

90 participants in 3 patient groups

Intrathecal Dexmedetomidine Group
Active Comparator group
Description:
30 patients will be given Intrathecal Dexmedetomidine plus Intrathecal Bupivacaine
Treatment:
Drug: Intrathecal Dexmedetomidine
Intraarticular Dexmedetomidine Group
Active Comparator group
Description:
30 patients will be given Intraarticular Dexmedetomidine plus Intrathecal Bupivacaine
Treatment:
Drug: Intraarticular Dexmedetomidine
control Group
Other group
Description:
30 patients will be given Intrathecal Bupivacaine
Treatment:
Drug: Bupivacaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems